BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35794829)

  • 21. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
    Huang L; Counter CM
    PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site.
    Chavan TS; Jang H; Khavrutskii L; Abraham SJ; Banerjee A; Freed BC; Johannessen L; Tarasov SG; Gaponenko V; Nussinov R; Tarasova NI
    Biophys J; 2015 Dec; 109(12):2602-2613. PubMed ID: 26682817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.
    Akkapeddi P; Hattori T; Khan I; Glasser E; Koide A; Ketavarapu G; Whaby M; Zuberi M; Teng KW; Lefler J; Maso L; Bang I; Ostrowski MC; O'Bryan JP; Koide S
    Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2302485120. PubMed ID: 37399416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.
    Wey M; Lee J; Jeong SS; Kim J; Heo J
    Biochemistry; 2013 Nov; 52(47):8465-79. PubMed ID: 24224811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.
    Felisiak-Goląbek A; Inaguma S; Kowalik A; Wasąg B; Wang ZF; Zięba S; Pięciak L; Ryś J; Kopczynski J; Sarlomo-Rikala M; Góźdź S; Lasota J; Miettinen M
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):40-45. PubMed ID: 29206715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS
    Zhou ZW; Ambrogio C; Bera AK; Li Q; Li XX; Li L; Son J; Gondi S; Li J; Campbell E; Jin H; Okoro JJ; Xu CX; Janne PA; Westover KD
    Cancer Res; 2020 Sep; 80(17):3719-3731. PubMed ID: 32605999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations.
    Hunter JC; Manandhar A; Carrasco MA; Gurbani D; Gondi S; Westover KD
    Mol Cancer Res; 2015 Sep; 13(9):1325-35. PubMed ID: 26037647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers.
    Araki M; Shima F; Yoshikawa Y; Muraoka S; Ijiri Y; Nagahara Y; Shirono T; Kataoka T; Tamura A
    J Biol Chem; 2011 Nov; 286(45):39644-53. PubMed ID: 21930707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions.
    Miller SP; Maio G; Zhang X; Badillo Soto FS; Zhu J; Ramirez SZ; Lin H
    Mol Cell Proteomics; 2022 Aug; 21(8):100268. PubMed ID: 35839996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II.
    Gebregiworgis T; Chan JY; Kuntz DA; Privé GG; Marshall CB; Ikura M
    Eur J Cell Biol; 2024 Apr; 103(2):151414. PubMed ID: 38640594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugging an undruggable pocket on KRAS.
    Kessler D; Gmachl M; Mantoulidis A; Martin LJ; Zoephel A; Mayer M; Gollner A; Covini D; Fischer S; Gerstberger T; Gmaschitz T; Goodwin C; Greb P; Häring D; Hela W; Hoffmann J; Karolyi-Oezguer J; Knesl P; Kornigg S; Koegl M; Kousek R; Lamarre L; Moser F; Munico-Martinez S; Peinsipp C; Phan J; Rinnenthal J; Sai J; Salamon C; Scherbantin Y; Schipany K; Schnitzer R; Schrenk A; Sharps B; Siszler G; Sun Q; Waterson A; Wolkerstorfer B; Zeeb M; Pearson M; Fesik SW; McConnell DB
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15823-15829. PubMed ID: 31332011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.
    Adhikari H; Counter CM
    Nat Commun; 2018 Sep; 9(1):3646. PubMed ID: 30194290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-type NRas and KRas perform distinct functions during transformation.
    Fotiadou PP; Takahashi C; Rajabi HN; Ewen ME
    Mol Cell Biol; 2007 Oct; 27(19):6742-55. PubMed ID: 17636015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.
    Kiessling MK; Oberholzer PA; Mondal C; Karpova MB; Zipser MC; Lin WM; Girardi M; Macconaill LE; Kehoe SM; Hatton C; French LE; Garraway LA; Polier G; Süss D; Klemke CD; Krammer PH; Gülow K; Dummer R
    Blood; 2011 Feb; 117(8):2433-40. PubMed ID: 21209378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRAS
    Bera AK; Lu J; Lu C; Li L; Gondi S; Yan W; Nelson A; Zhang G; Westover KD
    Birth Defects Res; 2020 Jun; 112(10):708-717. PubMed ID: 32187889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.
    Mazalouskas MD; Godoy-Ruiz R; Weber DJ; Zimmer DB; Honkanen RE; Wadzinski BE
    J Biol Chem; 2014 Feb; 289(7):4219-32. PubMed ID: 24371145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase.
    Buhrman G; Kumar VS; Cirit M; Haugh JM; Mattos C
    J Biol Chem; 2011 Feb; 286(5):3323-31. PubMed ID: 21098031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR
    Sharma AK; Dyba M; Tonelli M; Smith B; Gillette WK; Esposito D; Nissley DV; McCormick F; Maciag AE
    Biomol NMR Assign; 2022 Apr; 16(1):1-8. PubMed ID: 34686998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membrane.
    Van QN; López CA; Tonelli M; Taylor T; Niu B; Stanley CB; Bhowmik D; Tran TH; Frank PH; Messing S; Alexander P; Scott D; Ye X; Drew M; Chertov O; Lösche M; Ramanathan A; Gross ML; Hengartner NW; Westler WM; Markley JL; Simanshu DK; Nissley DV; Gillette WK; Esposito D; McCormick F; Gnanakaran S; Heinrich F; Stephen AG
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24258-24268. PubMed ID: 32913056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical roles of interactions among switch I-preceding residues and between switch II and its neighboring alpha-helix in conformational dynamics of the GTP-bound Ras family small GTPases.
    Matsumoto K; Shima F; Muraoka S; Araki M; Hu L; Ijiri Y; Hirai R; Liao J; Yoshioka T; Kumasaka T; Yamamoto M; Tamura A; Kataoka T
    J Biol Chem; 2011 Apr; 286(17):15403-12. PubMed ID: 21388959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.